Month: January 2025

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, announced that it will release its fourth quarter 2024 earnings before the market opens on Thursday, January 23, 2025. Valley’s CEO, Ira Robbins will host a conference call on Thursday, January 23, 2025 at 11:00 AM (ET) to discuss Valley’s fourth quarter 2024 earnings. Interested parties should pre-register using this link: https://register.vevent.com/register/BIae2379032fe94367aabe37b7eae5ab92 to receive the dial-in number and a personal PIN, which are required to access the conference call. The teleconference will also be webcast live: https://edge.media-server.com/mmc/p/z2siydrm and archived on Valley’s website through Monday, February 24, 2025. Investor presentation materials will be made available...

Half-year statement of the liquidity contract As of December 31, 2024 Voltalia (Euronext Paris, ISIN code: FR0011995588), announces that the Company’s liquidity account, which is managed by NATIXIS ODDO BHF under a liquidity contract, included the following cash and Company common shares as of December 31, 2024:53,758 shares €526,043.54 Number of transactions on buy side over the period: 2,654 Number of transactions on sell side over the period: 2,597 Volume traded on buy side over the period: 536,262 shares for €4,560,802 Volume traded on sell side over the period: 550,002 shares for €4,722,729As a reminder, when the contract started, the following cash and shares were allocated to the liquidity account:30,384 shares €1,000,000Next on the agenda: Q4 2024 turnover, January 29, 2025 (after market close)About Voltalia (www.voltalia.com)...

Half-yearly report on the liquidity contract Under the liquidity contract entrusted by Planisware SA to Rothschild Martin Maurel from May 13, 2024, the following resources were included in the liquidity account as of December, 31 2024:800 shares € 1,792,646During the period from 01/07/2024 to 31/12/2024 the following transactions were executed:  Number of transactions executed Traded volumesin number of shares Traded volumesin €Buy 5,583 222,037 5,876,888.84Sell 5,203 221,444 5,845,615.66It is recalled that as of June 30, 2024, the following means were included in the liquidity account:207 shares € 1,794,186Attachment20241231 – Planisware – Half-yearly report on the liquidity contract

Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF Boulogne-Billancourt (France), January 7th, 2025 – Under the liquidity agreement entrusted by IPSEN SA to NATIXIS ODDO BHF, as of December 31, 2024, the following resources were included to the dedicated liquidity account:24,701 shares €2,635,980.25It is reminded that as of the date of the implementation of the agreement, the following resources were allocated to the liquidity account:12,751 shares €3,137,934.80Between July 1st, 2024 and December 31st, 2024 have been executed:2,936 purchase transactions 2,346 sell transactionsUnder the same period, the volumes traded represented:311,792 shares and €33,997,824.80 to the purchase 321,682 shares and €35,215,771.10 to the selAttachmentIPSEN – PR Half year statement S2 2024 EN ...

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11Date Total number of shares composing the share capital Total number of voting rights (1)31 December 2024 83,814,526 Gross total* of voting rights: 131,939,858Net total** of voting rights: 130,834,785(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10). * Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit...

16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires: presentation of Professor Maestretti’s clinical results on the Sycamore device Fleurieux-sur-l’Arbresle – France – January 7, 2025 at 6pm. Safe announces that Professor Gianluca Maestretti, Head of Orthopaedics at the Freiburg Hospital, will present his clinical results on the Sycamore device at the 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires, to be held in Nice on January 24, 2025. Professor Maestretti, a recognized expert in orthopaedic surgery, will share his clinical observations on the use of Sycamore, an innovative device for the minimally invasive treatment of vertebral fractures. This presentation will be followed by a discussion with a panel of experts in interventional radiology, highlighting...

Strasbourg, January 7, 2025 – 06:00 pm CET Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2024, the following resources were managed through the liquidity account:359,661 shares € 80,653.30In the second half of 2024, a total of:Purchases 250,777 shares € 243,947.38 1,154 market transactionsSales 229 905 shares € 230,275.17 1,081 market transactionsIt is recalled that when the liquidity program was initially established in 2016, the following resources were made available:€ 500,000.00At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:164,183 shares € 246,158.00ContactsTransgene: Lucie LARGUIERCFO+33 (0)3 88 27 91 00investorrelations@transgene.fr  Attachment...

CALHOUN, Ga., Jan. 07, 2025 (GLOBE NEWSWIRE) — In conjunction with Mohawk Industries’ (NYSE: MHK) fourth quarter 2024 earnings release on Thursday, February 6, you are invited to listen to the conference call that will be broadcast live on Friday, February 7, at 11:00 am ET.What: Mohawk Industries’ Fourth Quarter Earnings Call   When: February 7, 2025  11:00 am ET   Where: www.mohawkind.com  Select “Investors” tab   How: Live over the Internet – Simply log on via the web at the address above or  Register for the conference call at: https://dpregister.com/sreg/10195645/fe39dbe57e  Live Conference Call:       Dial 1-833-630-1962 (U.S./Canada)                                       Dial 1-412-317-1843 (International)   For those unable to listen at the designated time, the call will remain...